In vitro splicing of fushi-tarazu transcripts. Splicing assays were carried out in nuclear extract (lane 1) or in a cytoplasmic S100 fraction (lanes 2-4) supplemented with 3 µl of 20-40% ammonium sulfate-precipitated (20-40% AS) fraction from HeLa nuclear extract and with/without 400 ng of purified recombinant SC35 or ASF/SF2 protein. Both proteins stimulated splicing to the same extent. (B) In vitro splicing of wild-type and mutant SC35-RI transcripts in the S100 fraction. Splicing assays were supplemented (or not) with 3 µl of 20-40% AS fraction and with/without 600 ng of purified wild-type SC35, as indicated. The different RNA transcripts are indicated above each panel. The pre-mRNA and various splicing products are symbolised on the side of the gel. Products resulting from the use of an exonic cryptic 3' splice site are marked by an asterisk. figure, and the results of the splicing assays (carried out in nuclear extract as described in Figure 2 ) are shown at the bottom. The sequences I, II and III (the positions relative to the terminal 3' splice site are indicated) tested in Figure 2 were subdivided into 2 or 3 shorter sequences. The minimal IIB sequence, which showed the highest splicing efficiency (lane 2) and which was analysed in details in this study, was further shortened. As in Figure 2 , the IIB-M sequence exhibited also a strong splicing activity (compare lanes 2 and 10).
Step-by-step replacement of dinucleotides by AA dinucleotides showed that the core sequence GUUGCAGU (in red) is important within the IIB-M sequence (lanes 11-13), whereas the mutation of the last dinucleotide has little effect on splicing (lane 14 compared to lane 10). 
Supplementary Figure 4
Supplementary Figure 4 . UV cross-linking. Labeled RNA probes indicated on top of the figure were incubated in different extracts, supplemented or not with 400 ng of recombinant FLAG-SC35, as mentioned on the left side of each panel. Samples were cross-linked and analysed as described in Cavaloc et al. (1999) . The position of endogenous (about 35 kDa) or FLAG-tagged SC35 (about 37 kDa) is shown on the right. No band was obtained around 35-37 kDa in the S100 extract in the absence of FLAG-SC35 (data not shown), so that the 37 kDa band observed in all lanes (except in the control lane C), when FLAG-SC35 was added to S100, results from cross-linking with FLAG-SC35 (top panel). This experiment shows a weak interaction of SC35 with the 4 RNAs from the SC35 terminal exon and a strong interaction with the SELEX-derived sequences S-94 and especially S-7. Endogenous SC35 from the nuclear extract (NE) was cross-linked only to the S-94 and S-7 RNA, and was barely detectable with other RNAs (second panel from top). In the 20-40% ammonium sulfate-precipitated fraction (the two bottom panels), an endogenous 37 kDa band was observed, which impaired the proper crosslinking of FLAG-SC35, except to the S-7 RNA. . Knock-down of SC35 expression results in a nearly complete inhibition of the SC35 3' splice site in the pSC35-βGlo minigene. HeLa cells were treated as described in Materials and Methods with siRNA targeting the SC35 gene or with control siRNA (targeting luciferase, Luc), transfected with the pSC35-β Glo minigene and analysed as in Figure 7 . The sequence of the SC35 siRNA was described in Gabut et al. (2005) . As in that study, the SC35 protein level was only decreased by about 50%, but the effect on the minigene was dramatic. The siRNA treatment did not modify the levels of hnRNP H and TDP-43. PTB/hnRNP I (green) bound more specifically to RNA III (see Figure 3C ). Proteins in black were associated to all RNAs in a non-specific manner and corresponded most of the time to major stained bands on the gels, which masked the presence of specific proteins. SC35 was identified as a strong interactor of RNA S-7 (blue) while only traces were found at the corresponding position in other lanes.
β-globin
Supplementary Figure 5 . Figure 1C . T: unspliced transcript.
As expected, an excess of RNA S-7, which has a high affinity for SC35, inhibited splicing of the SC35-RI transcript almost completely compared to controls performed without competitor or with the control RNA (lanes 6-7 compared to lanes 2 and 8, panel C for quantifications).
RNA II, which binds SC35 less efficiently, inhibited splicing only by about 50% (lane 5).
However, even though SC35 bound equally well to RNAs II and I (see Figure 3) , an excess of the latter did not affect splicing significantly (lanes 3-4). 
Supplementary Materials and Methods

Plasmids
To generate mutants 7-37 and 44-73 of the SC35-RI substrate, we used the newly created restriction sites to replace the corresponding fragments of terminal exon, respectively, by the same sequence: 5'-TTTCAGTTATTATGGTCCTTTAAC-3'. Shorter segments corresponding to nucleotides 7-23, 22-37, 44-58 and 61-73 were replaced respectively by the following sequences: 5'-TTTCAGTTATTATGG-3', 5'-TTTCAGTTATTATG-3', 5'-TTTCAGTTATTAT-3' and 5'-TTCAGTTATT-3'.
The wild-type Sp1 plasmid was described previously (Cavaloc et al., 1999) . Potential ESE sequences were inserted between KpnI and BamHI sites of its inverted exon 2. To generate the Sp1-ter-ex plasmid, an HpaI-SalI fragment from the second exon of Sp1 plasmid (positions +3 and +108 of exon), was replaced by a NheI-SalI fragment (112 bp) from SC35-RI exon 2.
All sequences used as matrices to transcribe short RNA for in vitro RNA-protein interactions and competition studies were cloned between KpnI and BamHI sites of the pBluescript-SK II(+) plasmid (Stratagene).
The pXJ41-hnRNP H construct was obtained by inserting the complete cDNA of hnRNP H1
(amplified by PCR from the pGST-hnRNP H plasmid) into BamHI and XhoI sites of the pXJ41 plasmid.
The pTT3-FLAG plasmid was derived from the pTT3 plasmid (Durocher et al., 2002) by adding a FLAG epitope between EcoRI and HindIII sites, in order to position the epitope upstream of cDNA sequences to insert. We then inserted a PCR fragment corresponding to the full-length TDP-43 cDNA (amplified from the pGEX-3X-TDP-43 plasmid kindly provided by E. Buratti) into HindIII and EagI sites of this vector to generate the pTT3-FLAG-TDP-43 construct.
Purification of hnRNP H RRM1-2.
Escherichia coli BL21 were used as recipient cells, grown at 37°C, in LB medium containing 100 mg/l of ampicillin. Expression of the His6-hnRNP H RRM1-2 protein was induced by addition of 1 mM IPTG followed by a 4 h incubation. Cells were lysed on ice by sonication in phosphate buffer (150 mM NaCl, 16 mM Na 2 HPO 4 , 4 mM NaH 2 PO 4 pH 7.3) containing 0.2 mM phenylmethyl sulfonyl fluoride (PMSF). Cell lysates were subjected to immobilized metal (Ni 2+ ) chelate affinity chromatography (Qiagen) in non denaturating conditions. The purified protein was dialyzed against a buffer containing 150 mM KCl, 1.5 mM MgCl 2 , 0.2 mM EDTA, 20 mM HEPES pH 7.9, 10% glycerol and stored at -80°C.
Expression and purification of recombinant GST-hnRNP H and GST-TDP-43
A primary culture of Escherichia coli BL21-Rosetta2 bacteria (Novagen) transformed with the pGEX-hnRNP H plasmid was grown at 37°C in standard LB medium supplemented with 0.1 mg/ml ampicillin and 0.04 mg/ml chloramphenicol. The culture was stopped when O.D.
(at 560 nm) reached ~0.5-0.6, cells were centrifuged and kept overnight on ice. The next morning, the culture was restarted at 37°C in 300 ml LB supplemented with ampicillin. After 3 h growth (O.D. ~0.3), the culture was transferred at room temperature and continued until an O.D. ~0.5-0.6. Protein expression was induced by adding 0.1 mM IPTG and culture was grown for another 3 h at 18°C (this low temperature helps solubilising and eluting the protein in later steps). Cells were centrifuged and frozen at -80°C. Cell pellets were resuspended in 13 ml of the following extraction buffer: 50 mM Tris-HCl pH 8.15, 0.5 M NaCl, 1% Triton X-100, 5 mM DTT, 10% glycerol, 0.3 mM PMSF and a protease inhibitor cocktail. 0.2 mg/ml lysozyme was added and cell suspension was kept for 10 min on ice and then sonicated to obtain a clear mixture, which was kept again on ice for 10 min and centrifuged at 14,000 g for 20 min to eliminate cell debris.
Protein purification was carried out on a PolyPrep column (Biorad). The crude protein extract was loaded slowly onto 0.8 ml GST-Sepharose (a higher volume may reduce the elution efficiency), and reloaded at least another time, allowing the binding of about 50% of the recombinant protein. The column was then washed with 6-8 ml of extraction buffer (without protease inhibitor cocktail). Elution was carried out in 3 steps. We first performed two elutions with 1-1.2 ml of a buffer containing 50 mM Tris-HCl pH 8.15, 0.5 M NaCl, 10% glycerol and 0.1% Triton X-100, supplemented with 30 mM glutathion (40 mM for the second elution). The flow rate was kept very slow (1 drop every 30-60 sec) and the dead volume of the column (~0.3 ml) was discarded. After the second elution, the resin was transfered into a 5 ml tube and a third elution was carried out overnight with 1.2 ml of elution buffer containing 40 mM glutathion. The different fractions were dialysed against buffer D and the final purity and concentration of purified GST-hnRNP H were analysed by SDS-PAGE and Coomassie staining of the gel. We estimated that 10% of bound protein were eluted in both E1 and E2 and another 20-25% in E3, while more than half of the protein remained stably associated to the resin. We did not try to elute more proteins using more stringent conditions.
Electrophoretic mobility shift assay (EMSA)
Constant amounts of in vitro transcribed RNA probes (5 to 10 fmol) were incubated with 10, 20 and 30 ng recombinant GST-SC35∆RS or with 30 ng GST-9G8∆RS and analysed as described previously (Cavaloc et al., 1999) .
RNA affinity chromatography
Briefly, 400 pmol of RNA were covalently immobilized on 150 µl beads (with a binding efficieny of 60 to 80%) and incubated with 300 µl HeLa nuclear extract (~2.4 mg), in the presence of 18 µg Escherichia coli tRNA and 100 µg bovine serum albumin. Excess of non specifically bound proteins was washed away using glycerol-free buffer D (20 mM HEPES, pH 7.9, 100 mM KCl, 0.2 mM EDTA, 0.5 mM DTT), and proteins that remained associated to the beads were resolved by SDS-PAGE in a 24 cm-long gel ( Supplementary Figure 3) .
Bands stained equally well in all lanes were used as loading control. Bands showing a stronger intensity in one lane compared to another, as well as bands of corresponding size in other lanes (as internal controls), were excised from the gel. Proteins were digested with trypsin and analysed by MALDI-TOF mass spectrometry as previously described (Venables et al., 2005) .
